Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Biologics and biosimilars [[electronic resource] ] : balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009
| Biologics and biosimilars [[electronic resource] ] : balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009 |
| Pubbl/distr/stampa | Washington : , : U.S. G.P.O., , 2010 |
| Descrizione fisica | 1 online resource (iv, 252 pages) : illustrations |
| Soggetto topico |
Drug development - Government policy - United States
Pharmaceutical biotechnology - Government policy - United States Pharmaceutical biotechnology - United States Biologicals - Government policy - United States |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Biologics and biosimilars |
| Record Nr. | UNINA-9910698589103321 |
| Washington : , : U.S. G.P.O., , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Emerging health care issues [[electronic resource] ] : follow-on biologic drug competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, June 11, 2009
| Emerging health care issues [[electronic resource] ] : follow-on biologic drug competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, June 11, 2009 |
| Pubbl/distr/stampa | Washington : , : U.S. G.P.O., , 2012 |
| Descrizione fisica | 1 online resource (vi, 283 pages) : illustrations |
| Soggetto topico |
Biologicals - Government policy - United States
Pharmaceutical biotechnology - Government policy - United States Drugs - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Emerging health care issues |
| Record Nr. | UNINA-9910703347403321 |
| Washington : , : U.S. G.P.O., , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Examining implementation of the Biologics Price Competition and Innovation Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016
| Examining implementation of the Biologics Price Competition and Innovation Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2016 |
| Descrizione fisica | 1 online resource (iii, 83 pages) |
| Soggetto topico |
Biologicals - Government policy - United States
Pharmaceutical biotechnology - Government policy - United States |
| Soggetto genere / forma | Legislative hearings. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Examining implementation of the Biologics Price Competition and Innovation Act |
| Record Nr. | UNINA-9910707992303321 |
| Washington : , : U.S. Government Publishing Office, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Follow-on biologics [[electronic resource] ] : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007
| Follow-on biologics [[electronic resource] ] : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007 |
| Pubbl/distr/stampa | Washington : , : U.S. G.P.O., , 2008 |
| Descrizione fisica | 1 electronic text (iv, 78 pages) : HTML, digital, PDF file |
| Collana | S. hrg. |
| Soggetto topico |
Pharmaceutical biotechnology - Government policy - United States
Pharmaceutical biotechnology - United States Pharmaceutical technology - Government policy - United States Drug development - Government policy - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Follow-on biologics |
| Record Nr. | UNINA-9910698695203321 |
| Washington : , : U.S. G.P.O., , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Guidance for industry [[electronic resource] ] : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products
| Guidance for industry [[electronic resource] ] : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products |
| Pubbl/distr/stampa | [Rockville, MD] : , : Center for Drug Evaluation and Research : , : Center for Biologics Evaluation and Research, , [1995] |
| Descrizione fisica | 1 online resource (i, 16 pages) |
| Soggetto topico |
Drugs - Testing - Government policy - United States
Pharmaceutical biotechnology - Government policy - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Guidance for industry |
| Record Nr. | UNINA-9910690381003321 |
| [Rockville, MD] : , : Center for Drug Evaluation and Research : , : Center for Biologics Evaluation and Research, , [1995] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
